119 results
Page 2 of 6
8-K
EX-99.1
s6yq09lf4g8bssmie261
9 May 23
Cogent Biosciences Reports Recent Business Highlights and First Quarter
8:13am
8-K
EX-99.1
86ccxkonq
12 Dec 22
Cogent Biosciences Announces Positive Updated Clinical Data from Ongoing Phase 2 APEX Trial Evaluating
8:03am
8-K
EX-99.1
od8we54mktgjczl tq
14 Nov 22
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2022 Financial Results
7:14am
8-K
EX-99.1
1yh1zmh826 f20byoy
9 Aug 22
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2022 Financial Results
7:15am
8-K/A
EX-1.1
d643h
16 Jun 22
Entry into a Material Definitive Agreement
5:03pm
8-K/A
EX-99.1
cxw 8mvqo0
16 Jun 22
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-1.1
y4fxe9fi2tvonp
15 Jun 22
Entry into a Material Definitive Agreement
5:18pm
8-K
EX-99.1
hx82 g6hrgex5
10 Jun 22
Submission of Matters to a Vote of Security Holders
7:12am
8-K
EX-99.1
kdc15foigcw2
10 May 22
Cogent Biosciences Reports Recent Business Highlights and First Quarter
7:31am
8-K
EX-99.1
uevobuca
15 Mar 22
Cogent Biosciences Provides Corporate Updates, Fourth Quarter
8:08am
8-K
EX-10.1
cq57bi
27 Dec 21
Departure of Directors or Certain Officers
4:05pm